Andrew Skibo - BWV Global Operations
Andrew Skibo is Portfolio Manager at BWV
Phone | 513 620 4101 |
Web | https://www.bluewatervaccines.com |
BWV Management Efficiency
The company has Return on Asset of (0.3022) % which means that on every $100 spent on assets, it lost $0.3022. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.0163) %, meaning that it generated no profit with money invested by stockholders. BWV's management efficiency ratios could be used to measure how well BWV manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
Showing other executives | One Year Return | ||
MD DrSc | Allarity Therapeutics | 81 | |
Claus Pedersen | Allarity Therapeutics | 52 | |
Cameron Shaw | Virax Biolabs Group | 37 | |
Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
James Rolke | Revelation Biosciences | 56 | |
MaryJane Rafii | Kiora Pharmaceuticals | N/A | |
MPA MD | Unicycive Therapeutics | 52 | |
Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
Melissa Tosca | Kiora Pharmaceuticals | N/A | |
Carol Odle | Revelation Biosciences | N/A | |
James JD | Allarity Therapeutics | 55 | |
James Foster | Virax Biolabs Group | 40 | |
Robert McRae | Palisade Bio | N/A | |
MD MBA | Kiora Pharmaceuticals | 52 | |
Meeshanthini Dogan | Cardio Diagnostics Holdings | 36 | |
MD FAAAAI | Palisade Bio | N/A | |
Tomasz George | Virax Biolabs Group | 40 | |
Steen Knudsen | Allarity Therapeutics | 64 | |
John CPA | Unicycive Therapeutics | 63 | |
Jason Davis | Virax Biolabs Group | 53 | |
Timur Dogan | Cardio Diagnostics Holdings | 36 |
Management Performance
Return On Equity | -1.02 | |||
Return On Asset | -0.3 |
BWV Money Managers
Theodore Yoho, Head Devel | ||
Erin Henderson, Chief Sec | ||
Brian Price, Head Strategy | ||
Andrew Skibo, Global Operations | ||
Jon Garfield, Chief Officer | ||
MBA MS, Pres CEO | ||
Ronald Cobb, Head Discovery |
BWV Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BWV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.02 | |||
Return On Asset | -0.3 | |||
Current Valuation | 8.81 M | |||
Shares Outstanding | 18.66 M | |||
Shares Owned By Insiders | 17.69 % | |||
Shares Owned By Institutions | 23.44 % | |||
Number Of Shares Shorted | 23.33 K | |||
Price To Book | 0.35 X | |||
EBITDA | (13.54 M) | |||
Net Income | (13.42 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Tools for BWV Etf
When running BWV's price analysis, check to measure BWV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BWV is operating at the current time. Most of BWV's value examination focuses on studying past and present price action to predict the probability of BWV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BWV's price. Additionally, you may evaluate how the addition of BWV to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |